C12Y 101/01225
Chlordecone reductase
Official title: Chlordecone reductase (1.1.1.225)
C12Y101/01225 (Chlordecone reductase) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 3
- Assignees
- 3
- Inventors
- 18
- Latest grant
- 19 Apr 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 2 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
By publication year.
Recent patents
- 3α-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid19 Apr 2022US 11,306,343 B2PharmaZell GmbH
- 3-alpha-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid26 Nov 2019US 10,487,348 B2PharmaZell GmbH
- Composition and method for treating androgen-dependent disorders26 Mar 2019US 10,240,132 B2Technion Research & Development Foundation Limited
- 3-alpha-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid26 Dec 2019US 2019/0390242 A1PharmaZell GmbH
- 3-Alpha-Hydroxysteroid Dehydrogenase Mutants and Process for the Preparation of Ursodeoxycholic Acid26 Oct 2017US 2017/0306382 A1PharmaZell GmbH
- Composition and method for treating androgen-dependent disorders28 Sep 2017US 2017/0275596 A1Technion Research & Development Foundation Limited
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.